Breaking News Instant updates and real-time market news.

2021-01-19 20:25:00 PG Procter & Gamble $133.56 / -1.275 (-0.95%) , UNH UnitedHealth $352.10 / +0.995 (+0.28%) … 20:25 01/19/21 01/19 20:25 01/19/21 20:25	Notable companies reporting before tomorrow's open Notable companies reporting before tomorrow's open, with earnings consensus, include Procter & Gamble (PG), consensus $1.51... UnitedHealth (UNH), consensus $2.41... Morgan Stanley (MS), consensus $1.27... U.S. Bancorp (USB), consensus 95c... Bank of New York Mellon (BK), consensus 91c... Fastenal (FAST), consensus 33c... Citizens Financial (CFG), consensus 91c. PG Procter & Gamble $133.56 / -1.275 (-0.95%) UNH UnitedHealth $352.10 / +0.995 (+0.28%) MS Morgan Stanley $74.99 / -0.23 (-0.31%) USB U.S. Bancorp $48.05 / -0.39 (-0.81%) BK BNY Mellon $45.81 / +0.24 (+0.53%) FAST Fastenal $50.42 / -0.08 (-0.16%) CFG Citizens Financial $40.83 / +0.18 (+0.44%)	20 Jan 20 Jan 20 Jan 20 Jan 20 Jan 20 Jan 20 Jan 25 Jan 01 Feb 24 Feb
PG UNH MS USB BK FAST CFG PG Procter & Gamble $133.56 / -1.275 (-0.95%) 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 12/07/20 Wells Fargo Colgate-Palmolive initiated with an Underweight at Wells Fargo UNH UnitedHealth $352.10 / +0.995 (+0.28%) 01/07/21 Wells Fargo Change Healthcare downgraded to Equal Weight from Overweight at Wells Fargo 01/07/21 Cowen Change Healthcare downgraded to Market Perform from Outperform at Cowen 01/07/21 Deutsche Bank UnitedHealth price target raised to $404 from $359 at Deutsche Bank 01/07/21 RBC Capital Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital MS Morgan Stanley $74.99 / -0.23 (-0.31%) 01/11/21 Piper Sandler Morgan Stanley price target raised to $76 from $54 at Piper Sandler 01/06/21 Deutsche Bank Morgan Stanley price target raised to $68 from $53 at Deutsche Bank 01/04/21 Fly Intel: Top five analyst upgrades 01/04/21 Barclays Morgan Stanley upgraded to Overweight with $88 target at Barclays USB U.S. Bancorp $48.05 / -0.39 (-0.81%) 01/07/21 Jefferies U.S. Bancorp upgraded to Buy with $58 price target at Jefferies 01/07/21 BofA U.S. Bancorp downgraded to Underperform from Neutral at BofA 01/07/21 Jefferies U.S. Bancorp upgraded to Buy from Hold at Jefferies 01/06/21 Deutsche Bank U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank BK BNY Mellon $45.81 / +0.24 (+0.53%) 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi 01/11/21 Piper Sandler BNY Mellon price target raised to $47 from $40 at Piper Sandler 01/05/21 Goldman Sachs Northern Trust downgraded to Sell from Neutral at Goldman Sachs FAST Fastenal $50.42 / -0.08 (-0.16%) 12/31/20 William Blair Azek, Trex among Blair's top Specialty Distribution ideas for 2021 12/16/20 Deutsche Bank Fastenal downgraded to Hold from Buy at Deutsche Bank 10/15/20 Stephens Fastenal resumed with an Overweight at Stephens 10/15/20 Argus Fastenal price target raised to $52 from $43 at Argus CFG Citizens Financial $40.83 / +0.18 (+0.44%) 01/12/21 UBS UBS downgrades Citizens on revenue headwinds, Wells new top pick 01/11/21 UBS Citizens Financial downgraded to Neutral from Buy at UBS 01/06/21 Deutsche Bank Citizens Financial price target raised to $41 from $31 at Deutsche Bank 01/04/21 Barclays Citizens Financial price target raised to $44 from $35 at Barclays

2021-01-19 20:25:00

Procter & Gamble

$133.56 / -1.275 (-0.95%)

, UNH

UnitedHealth

$352.10 / +0.995 (+0.28%)

… 20:25

01/19/21

01/19

20:25

01/19/21

20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Procter & Gamble (PG), consensus $1.51... UnitedHealth (UNH), consensus $2.41... Morgan Stanley (MS), consensus $1.27... U.S. Bancorp (USB), consensus 95c... Bank of New York Mellon (BK), consensus 91c... Fastenal (FAST), consensus 33c... Citizens Financial (CFG), consensus 91c.

Procter & Gamble

$133.56 / -1.275 (-0.95%)

UNH

UnitedHealth

$352.10 / +0.995 (+0.28%)

Morgan Stanley

$74.99 / -0.23 (-0.31%)

USB

U.S. Bancorp

$48.05 / -0.39 (-0.81%)

BNY Mellon

$45.81 / +0.24 (+0.53%)

FAST

Fastenal

$50.42 / -0.08 (-0.16%)

CFG

Citizens Financial

$40.83 / +0.18 (+0.44%)

20
Jan
20
Jan
20
Jan
20
Jan
20
Jan
20
Jan
20
Jan
25
Jan
01
Feb
24
Feb

PG
UNH
MS
USB
BK
FAST
CFG

PG Procter & Gamble

$133.56 / -1.275 (-0.95%)

01/19/21 Bernstein: Procter & Gamble initiated with a Market Perform at Bernstein

01/13/21 Deutsche Bank: Procter & Gamble price target raised to $159 from $156 at Deutsche Bank

01/06/21 Evercore ISI: PepsiCo downgraded to In Line to reflect macro view at Evercore ISI

12/07/20 Wells Fargo: Colgate-Palmolive initiated with an Underweight at Wells Fargo

UNH UnitedHealth

$352.10 / +0.995 (+0.28%)

01/07/21 Wells Fargo: Change Healthcare downgraded to Equal Weight from Overweight at Wells Fargo

01/07/21 Cowen: Change Healthcare downgraded to Market Perform from Outperform at Cowen

01/07/21 Deutsche Bank: UnitedHealth price target raised to $404 from $359 at Deutsche Bank

01/07/21 RBC Capital: Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital

MS Morgan Stanley

$74.99 / -0.23 (-0.31%)

01/11/21 Piper Sandler: Morgan Stanley price target raised to $76 from $54 at Piper Sandler

01/06/21 Deutsche Bank: Morgan Stanley price target raised to $68 from $53 at Deutsche Bank

01/04/21: Fly Intel: Top five analyst upgrades

01/04/21 Barclays: Morgan Stanley upgraded to Overweight with $88 target at Barclays

USB U.S. Bancorp

$48.05 / -0.39 (-0.81%)

01/07/21 Jefferies: U.S. Bancorp upgraded to Buy with $58 price target at Jefferies

01/07/21 BofA: U.S. Bancorp downgraded to Underperform from Neutral at BofA

01/07/21 Jefferies: U.S. Bancorp upgraded to Buy from Hold at Jefferies

01/06/21 Deutsche Bank: U.S. Bancorp price target raised to $55 from $46 at Deutsche Bank

BK BNY Mellon

$45.81 / +0.24 (+0.53%)

01/11/21 Citi: BNY Mellon upgraded to Buy from Neutral at Citi

01/11/21 Citi: BNY Mellon upgraded to Buy from Neutral at Citi

01/11/21 Piper Sandler: BNY Mellon price target raised to $47 from $40 at Piper Sandler

01/05/21 Goldman Sachs: Northern Trust downgraded to Sell from Neutral at Goldman Sachs

FAST Fastenal

$50.42 / -0.08 (-0.16%)

12/31/20 William Blair: Azek, Trex among Blair's top Specialty Distribution ideas for 2021

12/16/20 Deutsche Bank: Fastenal downgraded to Hold from Buy at Deutsche Bank

10/15/20 Stephens: Fastenal resumed with an Overweight at Stephens

10/15/20 Argus: Fastenal price target raised to $52 from $43 at Argus

CFG Citizens Financial

$40.83 / +0.18 (+0.44%)

01/12/21 UBS: UBS downgrades Citizens on revenue headwinds, Wells new top pick

01/11/21 UBS: Citizens Financial downgraded to Neutral from Buy at UBS

01/06/21 Deutsche Bank: Citizens Financial price target raised to $41 from $31 at Deutsche Bank

01/04/21 Barclays: Citizens Financial price target raised to $44 from $35 at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks	Hookipa Pharma announces publication on alternating 2-vector cancer therapeutics » 07:29 03/04/21 03/04 07:29 03/04/21 07:29 HOOK Hookipa Pharma $12.00 / +0.05 (+0.42%) HOOKIPA Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events HOOK Hookipa Pharma $12.00 / +0.05 (+0.42%) 12/07/20 Hookipa Pharma reports 'positive' interim Phase 1 data on HB-201 11/30/20 Hookipa Pharma announces Phase 2 interim safety, efficacy results for HB-101 10/29/20 Hookipa Pharma doses first patient in Phase 1/2 trial for HB-202/HB-201 therapy 10/19/20 Hookipa Pharma appoints Jean-Charles Soria to board of directors HOOK Hookipa Pharma $12.00 / +0.05 (+0.42%) 11/30/20 JMP Securities Hookipa Pharma price target raised to $25 from $19 at JMP Securities 11/03/20 Fly Intel: Top five analyst initiations 11/03/20 Truist Hookipa Pharma initiated with a Buy at Truist 11/03/20 Truist Hookipa Pharma initiated with a Buy at Truist HOOK Hookipa Pharma $12.00 / +0.05 (+0.42%) 11/12/20 Hookipa Pharma reports Q3 EPS (53c), consensus (43c) 09 Dec HOOK Hookipa Pharma $12.00 / +0.05 (+0.42%) 12/08/20 Fly Intel: After-Hours Movers 03/15/21 Hookipa Pharma - HOOK
Upgrade	Williams upgraded to Outperform from Sector Perform at Scotiabank » 07:29 03/04/21 03/04 07:29 03/04/21 07:29 WMB Williams $23.73 / +0.02 (+0.08%) Scotiabank analyst Alonso… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options WMB Williams $23.73 / +0.02 (+0.08%) 01/26/21 Williams raises quarterly dividend to 41c from 40c 12/17/20 Williams' resolution with Chesapeake receives bankruptcy court approval 11/23/20 Williams announces global resolution with Chesapeake WMB Williams $23.73 / +0.02 (+0.08%) 02/24/21 Mizuho Williams price target raised to $27 from $26 at Mizuho 01/20/21 Mizuho Williams price target raised to $26 from $24 at Mizuho 12/17/20 Credit Suisse Williams upgraded to Outperform from Neutral at Credit Suisse 12/11/20 Morgan Stanley Morgan Stanley upgrades midstream industry view to Attractive, shakes up ratings WMB Williams $23.73 / +0.02 (+0.08%) 02/22/21 Williams sees FY21 adjusted EBITDA of $5.05B-$5.35B 02/22/21 Williams reports Q4 adjusted EPS 31c, consensus 31c 11/02/20 Williams sees 2020 Adjusted EBITDA in lower half of guidance range 11/02/20 Williams reports Q3 adjusted EPS 27c, consensus 27c WMB Williams $23.73 / +0.02 (+0.08%) 10/14/20 Fly Intel: After-Hours Movers WMB Williams $23.73 / +0.02 (+0.08%) 10/09/20 Williams call volume above normal and directionally bullish 10/07/20 Williams put volume heavy and directionally bearish 10/05/20 Unusually active option classes on open October 5th
Hot Stocks	Landos Biopharma says all endpoints in Phase 1 study of NX-13 met » 07:28 03/04/21 03/04 07:28 03/04/21 07:28 LABP Landos Biopharma $15.22 / +0.73 (+5.04%) Landos Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly LABP Landos Biopharma $15.22 / +0.73 (+5.04%) 02/08/21 Landos Biopharma jumps 16% after disclosing insider buys 01/04/21 Landos Biopharma announces results from Phase 2 trial of BT-11 LABP Landos Biopharma $15.22 / +0.73 (+5.04%) 03/01/21 Jefferies Landos Biopharma initiated with a Buy at Jefferies 03/01/21 JPMorgan Landos Biopharma initiated with a Neutral at JPMorgan 03/01/21 Raymond James Landos Biopharma initiated with an Outperform at Raymond James 03/01/21 SVB Leerink Landos Biopharma initiated with an Outperform at SVB Leerink 04 Feb LABP Landos Biopharma $15.22 / +0.73 (+5.04%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Downgrade	Regency Centers downgraded to Hold from Buy at Argus » 07:27 03/04/21 03/04 07:27 03/04/21 07:27 REG Regency Centers $56.67 / +2.525 (+4.66%) Argus analyst Jacob… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options REG Regency Centers $56.67 / +2.525 (+4.66%) 03/02/21 PS Business Parks appoints Dan Chandler as CEO 03/02/21 Regency Centers chief investment officer Mac Chandler to resign 01/27/21 Regency Centers issues TCFD Climate Change Risk Report 01/19/21 Regency Centers sold five shopping centers in Q4 for $77.8M REG Regency Centers $56.67 / +2.525 (+4.66%) 01/25/21 Compass Point Regency Centers upgraded to Buy from Neutral at Compass Point 12/30/20 Truist Regency Centers price target raised to $50 from $45 at Truist 08/19/20 Fly Intel: Top five analyst downgrades 08/19/20 Compass Point Compass Point downgrades Regency Centers on 'tactical valuation call' REG Regency Centers $56.67 / +2.525 (+4.66%) 02/11/21 Regency Centers sees FY21 FFO $2.96-$3.14, consensus $3.31 02/11/21 Regency Centers reports Q4 FFO 76c, consensus 72c 11/05/20 Regency Centers reports Q3 EPS 7c, consensus 21c REG Regency Centers $56.67 / +2.525 (+4.66%) 12/29/20 Early notable gainers among liquid option names on December 29th
Hot Stocks	NewAge enters LOI to acquire Japan-based Aliven for approx. 1M shares » 07:26 03/04/21 03/04 07:26 03/04/21 07:26 NBEV NewAge $2.82 / -0.1 (-3.43%) NewAge announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NBEV NewAge $2.82 / -0.1 (-3.43%) 02/16/21 NewAge announces $58M private placement 12/01/20 NewAge announces $30M debt facility 11/19/20 NewAge appoints Fred Cooper to board of directors 10/15/20 NewAge's DSD Division on track for double-digit organic growth in 2020 NBEV NewAge $2.82 / -0.1 (-3.43%) 07/21/20 Alliance Global Partners New Age Beverages price target raised to $5 from $3.50 at Alliance Global 04/14/20 Alliance Global Partners New Age Beverages at Alliance Global Partners 03/11/20 Compass Point New Age Beverages price target lowered to $4 from $9 at Compass Point NBEV NewAge $2.82 / -0.1 (-3.43%) 02/16/21 NewAge ses Q4 net revenue in $90M range, consensus $79.34M 11/09/20 NewAge reports Q3 EPS (14c), consensus (6c) NBEV NewAge $2.82 / -0.1 (-3.43%) 11/09/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 NewAge - NBEV

Recommendations	Main Street price target raised to $40 from $34 at RBC Capital » 07:25 03/04/21 03/04 07:25 03/04/21 07:25 MAIN Main Street $37.33 / +0.63 (+1.72%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MAIN Main Street $37.33 / +0.63 (+1.72%) 01/20/21 Main Street reports Q4 private loan activity 01/19/21 Capital Southwest supports O2's investment in Flip Electronics 01/07/21 Main Street announces new portfolio investment MAIN Main Street $37.33 / +0.63 (+1.72%) 08/12/20 Truist Main Street price target raised to $33 from $28 at Truist 04/15/20 National Securities Main Street downgraded to Neutral from Buy at National Securities 03/17/20 National Securities Main Street upgraded to Buy from Neutral at National Securities MAIN Main Street $37.33 / +0.63 (+1.72%) 02/25/21 Main Street reports Q4 NII 59c, consensus 51c 11/05/20 Main Street reports Q3 NII 46c, consensus 47c
Recommendations	Exxon Mobil price target raised to $60 from $57 at Morgan Stanley » 07:25 03/04/21 03/04 07:25 03/04/21 07:25 XOM Exxon Mobil $56.52 / +0.45 (+0.80%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 03/03/21 Exxon Mobil must change direction, not just appoint board candidates, CURE says 03/03/21 Exxon Mobil sees FY21 capital spending $16B-$19B 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 07:13 Today Truist Exxon Mobil price target raised to $60 from $50 at Truist 06:14 Today Citi Exxon Mobil price target raised to $53 from $44 at Citi 03/02/21 Wells Fargo Exxon Mobil price target raised to $65 from $53 at Wells Fargo 02/26/21 Barclays Exxon Mobil price target raised to $65 from $59 at Barclays XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 03/02/21 Exxon CEO says economics, policies creating carbon capture market, Reuters says 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports 02/17/21 Texas prohibits natgas firms from taking fuel out of state, Bloomberg says 02/17/21 Saudis to raise oil output as prices recover, WSJ reports XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Wall Street's top stories for Tuesday XOM Exxon Mobil $56.52 / +0.45 (+0.80%) 03/03/21 Exxon Mobil call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish
Hot Stocks	VBL Therapeutics announces publication of interim analysis of OVAL study » 07:24 03/04/21 03/04 07:24 03/04/21 07:24 VBLT VBL Therapeutics $1.83 / -0.12 (-6.15%) VBL Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VBLT VBL Therapeutics $1.83 / -0.12 (-6.15%) 03/01/21 VBL Therapeutics announces patient dosing in VB-111 trial 02/22/21 VBL Therapeutics says DSMC recommends continuation of OVAL Phase 3 study 01/27/21 VBL Therapeutics doses first patient in Phase 2 study of VB-201 01/15/21 VBL Therapeutics enters into share purchase agreement with Aspire Capital VBLT VBL Therapeutics $1.83 / -0.12 (-6.15%) 01/28/21 H.C. Wainwright VBL Therapeutics price target raised to $4 from $3 at H.C. Wainwright VBLT VBL Therapeutics $1.83 / -0.12 (-6.15%) 11/16/20 VBL Therapeutics reports Q3 EPS (12c), consensus (13c) VBLT VBL Therapeutics $1.83 / -0.12 (-6.15%) 12/30/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference
Hot Stocks	Fulcrum Therapeutics CEO Robert Gould to retire, Bryan Stuart to succeed » 07:23 03/04/21 03/04 07:23 03/04/21 07:23 FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) Fulcrum Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 07:16 Today Fulcrum Therapeutics expects cash to fund requirements into 4Q22 07:16 Today Fulcrum Therapeutics decides to discontinue LOSVID Phase 3 trial 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 03/01/21 Stifel Fulcrum Therapeutics initiated with a Buy at Stifel 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 07:15 Today Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 20 Jan 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:00 Today Fulcrum Therapeutics - FULC
Recommendations	General Electric price target raised to $17 from $13 at Morgan Stanley » 07:22 03/04/21 03/04 07:22 03/04/21 07:22 GE General Electric $13.45 / +0.48 (+3.70%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GE General Electric $13.45 / +0.48 (+3.70%) 02/24/21 Altair acquires Flow Simulator sofftware from GE Aviation 02/17/21 General Electric focusing on growing through existing business lines, CEO says 02/17/21 General Electric CEO says unlikely to do large M&A deals soon 02/12/21 Trian Fund exits nVent, increases stake in GE GE General Electric $13.45 / +0.48 (+3.70%) 03/02/21 Barclays Danaher started at Overweight at Barclays on GE biopharma business potential 02/22/21 Goldman Sachs General Electric price target raised to $15 at Goldman Sachs after meetings 01/28/21 Barclays General Electric price target raised to $13 from $12 at Barclays 01/27/21 Morgan Stanley General Electric price target raised to $13 from $12 at Morgan Stanley GE General Electric $13.45 / +0.48 (+3.70%) 01/26/21 General Electric sees FY21 adjusted EPS 15c-25c, consensus 38c 01/26/21 General Electric reports Q4 adjusted EPS 8c, consensus 9c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open GE General Electric $13.45 / +0.48 (+3.70%) 02/16/21 General Electric sees negative cash flow in Q1, Reuters reports 02/11/21 Southwest in talks for at least 300 new 150-seat planes, Air Current says 01/14/21 GE says Siemens stole trade secrets in bid to rig contracts , Reuters reports 01/11/21 GE to pause donations to lawmakers who voted against Biden win, Bloomberg says GE General Electric $13.45 / +0.48 (+3.70%) 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Pre-market Movers 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 03/10/21 General Electric Co. GE General Electric $13.45 / +0.48 (+3.70%) 02/24/21 General Electric call volume above normal and directionally bullish 01/26/21 Early notable gainers among liquid option names on January 26th 01/06/21 General Electric call volume above normal and directionally bullish 12/23/20 Notable open interest changes for December 23rd

Hot Stocks	DeepGreen Metals enters $2.9B combination agreement with SOAC » 07:22 03/04/21 03/04 07:22 03/04/21 07:22 SOAC Sustainable Opportunities Acquisition Corp. $10.22 / -0.2 (-1.92%) DeepGreen Metals … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Options SOAC Sustainable Opportunities Acquisition Corp. $10.22 / -0.2 (-1.92%) 02/23/21 DeepGreen Metals in talks to become public through SOAC merger, Bloomberg says SOAC Sustainable Opportunities Acquisition Corp. $10.22 / -0.2 (-1.92%) 03/02/21 Sustainable Opportunities Acquisition Corp (Class A Stock) call volume above normal and directionally bullish
Hot Stocks	Kronos Bio to initiate Phase 3 trial of entospletinib in mid-2021 » 07:21 03/04/21 03/04 07:21 03/04/21 07:21 KRON Kronos Bio $28.75 / -0.66 (-2.24%) Kronos Bio announced,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options KRON Kronos Bio $28.75 / -0.66 (-2.24%) 02/25/21 Kronos Bio announces first patient dosed in Phase 1/2 KB-0742 trial 01/26/21 Kronos Bio appoints Marianne De Backer to board of directors 12/08/20 Kronos Bio appoints Pasit Phiasivongsa as SVP, pharmaceutical development 12/07/20 Kronos Bio announces FDA clearance of IND application for KB-0742 KRON Kronos Bio $28.75 / -0.66 (-2.24%) 11/03/20 Fly Intel: Top five analyst initiations 11/03/20 Jefferies Kronos Bio initiated with a Buy at Jefferies 11/03/20 Piper Sandler Kronos Bio initiated with an Overweight at Piper Sandler 11/03/20 Goldman Sachs Kronos Bio initiated with a Buy at Goldman Sachs KRON Kronos Bio $28.75 / -0.66 (-2.24%) 11/18/20 Kronos Bio reports Q3 EPS ($6.48), consensus ($1.47) 09 Oct KRON Kronos Bio $28.75 / -0.66 (-2.24%) 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions KRON Kronos Bio $28.75 / -0.66 (-2.24%) 01/28/21 new option listings on January 28th
Hot Stocks	Sol-Gel Technologies expects cash to fund requirements into 3Q22 » 07:20 03/04/21 03/04 07:20 03/04/21 07:20 SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 12/07/20 Sol-Gel Technologies announces FDA acceptance of NDA filing for Twyneo 11/12/20 Sol-Gel Technologies expects cash to fund operations into 3Q21 09/10/20 Sol-Gel Technologies NDA for Epsolay accepted for filing by FDA SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 03/26/20 H.C. Wainwright Sol-Gel Technologies price target lowered to $21 from $26 at H.C. Wainwright SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 07:19 Today Sol-Gel Technologies reports 2020 EPS ($1.30), consensus ($1.48) 11/12/20 Sol-Gel Technologies reports Q3 EPS (37c), consensus (46c) SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 09/11/20 Fly Intel: Pre-market Movers
Hot Stocks	Shift4 Payments announces acquisition of VenueNext, terms undisclosed » 07:19 03/04/21 03/04 07:19 03/04/21 07:19 FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) Shift4 Payments announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) 01/07/21 Shift4 Payments, Sightline Payments announce strategic parntership 12/01/20 Shift4 Payments falls -7.8% 11/05/20 Shift4 Payments acquires 3dcart ecommerce platform, terms not disclosed 10/14/20 Shift4 Payments sees Q3 payment volume $7.0B-$7.1B FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) 01/06/21 Wolfe Research Shift4 Payments downgraded to Peer Perform from Outperform at Wolfe Research 01/06/21 BofA Shift4 Payments double-downgraded to Underperform from Buy at BofA 12/21/20 Fly Intel: Top five analyst initiations 12/21/20 Piper Sandler Shift4 Payments initiated with an Overweight at Piper Sandler FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) 07:09 Today Shift4 Payments sees FY21 revenue $1.1B-$1.2B, consensus $1.08B 07:06 Today Shift4 Payments reports Q4 adjusted EPS (5c), consensus 2c 11/05/20 Shift4 Payments reports Q3 EPS (12c), consensus 5c 11/04/20 Notable companies reporting before tomorrow's open 03 Dec 11 Sep 05 Jun FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) 11/30/20 Fly Intel: After-Hours Movers 11/05/20 Fly Intel: Pre-market Movers 08:30 Today Shift4 Payments - FOUR FOUR Shift4 Payments $71.06 / -4.24 (-5.63%) 12/14/20 Largest borrow rate increases among liquid names
Earnings	Sol-Gel Technologies reports 2020 EPS ($1.30), consensus ($1.48) » 07:19 03/04/21 03/04 07:19 03/04/21 07:19 SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) Reports 2020 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 12/07/20 Sol-Gel Technologies announces FDA acceptance of NDA filing for Twyneo 11/12/20 Sol-Gel Technologies expects cash to fund operations into 3Q21 09/10/20 Sol-Gel Technologies NDA for Epsolay accepted for filing by FDA SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 03/26/20 H.C. Wainwright Sol-Gel Technologies price target lowered to $21 from $26 at H.C. Wainwright SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 11/12/20 Sol-Gel Technologies reports Q3 EPS (37c), consensus (46c) SLGL Sol-Gel Technologies $9.58 / -0.05 (-0.52%) 09/11/20 Fly Intel: Pre-market Movers

Downgrade	Retail Properties of America downgraded to Sector Weight at KeyBanc » 07:18 03/04/21 03/04 07:18 03/04/21 07:18 RPAI Retail Properties of America $10.99 / +0.51 (+4.87%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RPAI Retail Properties of America $10.99 / +0.51 (+4.87%) 12/08/20 Retail Properties of America raises quarterly dividend to 6c from 5c per share 09/08/20 Retail Properties of America resumes dividend payment and provides update RPAI Retail Properties of America $10.99 / +0.51 (+4.87%) 05:20 Today KeyBanc Retail Properties downgraded to Sector Weight from Overweight at KeyBanc 12/15/20 Citi Retail Properties of America price target raised to $9.50 from $7 at Citi 11/10/20 Compass Point Compass Point upgrades four retail REITs to Neutral after Pfizer 'game changer' 11/09/20 Compass Point Retail Properties of America upgraded to Neutral from Sell at Compass Point RPAI Retail Properties of America $10.99 / +0.51 (+4.87%) 02/16/21 Retail Properties of America sees FY21 operating FFO 76c-84c 02/16/21 Retail Properties of America reports Q4 operating FFO 20c, consensus 21c 11/02/20 Retail Properties of America reports Q3 operating FFO 21, consensus 20c 05/05/21 Retail Properties of America - RPAI
Hot Stocks	Fulcrum Therapeutics expects cash to fund requirements into 4Q22 » 07:16 03/04/21 03/04 07:16 03/04/21 07:16 FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 07:16 Today Fulcrum Therapeutics decides to discontinue LOSVID Phase 3 trial 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease 12/06/20 Fulcrum Therapeutics presents updated data on SCD program FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 03/01/21 Stifel Fulcrum Therapeutics initiated with a Buy at Stifel 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 07:15 Today Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 20 Jan 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:00 Today Fulcrum Therapeutics - FULC
Upgrade	Site Centers upgraded to Overweight at KeyBanc » 07:16 03/04/21 03/04 07:16 03/04/21 07:16 SITC Site Centers $12.89 / +0.1 (+0.78%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events SITC Site Centers $12.89 / +0.1 (+0.78%) 01/12/21 Site Centers provides Q4 operational update SITC Site Centers $12.89 / +0.1 (+0.78%) 05:19 Today KeyBanc Site Centers upgraded to Overweight from Sector Weight at KeyBanc 02/23/21 Mizuho Site Centers price target raised to $13 from $10.50 at Mizuho 01/14/21 Piper Sandler Site Centers upgraded to Overweight from Neutral at Piper Sandler 12/15/20 Citi Site Centers price target raised to $11 from $8.50 at Citi SITC Site Centers $12.89 / +0.1 (+0.78%) 02/18/21 Site Centers sees 2021 operating FFO 90c-$1.00, consensus 98c 02/18/21 Site Centers reports Q4 operating FFO 25c, consensus 24c 10/27/20 Site Centers reports Q3 operating FFO 23c, consensus 23c 02 Mar 03/17/21 Site Centers
Hot Stocks	Fulcrum Therapeutics decides to discontinue LOSVID Phase 3 trial » 07:16 03/04/21 03/04 07:16 03/04/21 07:16 FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) After careful… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease 12/06/20 Fulcrum Therapeutics presents updated data on SCD program 11/10/20 Fulcrum Therapeutics: Curtis Oltmans to join as general counsel FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 03/01/21 Stifel Fulcrum Therapeutics initiated with a Buy at Stifel 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 07:15 Today Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 20 Jan 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:00 Today Fulcrum Therapeutics - FULC
Initiation	Wheaton Precious Metals initiated with an Overweight at JPMorgan » 07:16 03/04/21 03/04 07:16 03/04/21 07:16 WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) JPMorgan analyst Tyler… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 02/10/21 Wheaton Precious Metals sees 2021 production 720K-780K gold eq. oz. 02/01/21 Silver producers up in pre-market on r/wallstreetbets short squeeze speculation 12/11/20 Wheaton Precious Metals to acquire Mexico silver stream from Capstone for $150M 11/09/20 Wheaton Precious Metals raises quarterly dividend 20% to 12c per share WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 03/01/21 Berenberg Wheaton Precious Metals price target raised to 3,700 GBp at Berenberg 02/16/21 Berenberg Wheaton Precious Metals price target lowered to 3,500 GBp from 3,700 GBp at Berenberg 02/08/21 Stifel Wheaton Precious Metals upgraded to Buy from Hold at Stifel 02/02/21 Credit Suisse Wheaton Precious Metals price target lowered to C$62 from C$64 at Credit Suisse WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 11/09/20 Wheaton Precious Metals reports Q3 EPS 33c, consensus 33c WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 02/01/21 CME raises Silver futures margins by 18% to curb volatility, Bloomberg says WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 03/12/21 Wheaton Precious Metals - WPM WPM Wheaton Precious Metals $35.82 / -1.05 (-2.85%) 02/17/21 Wheaton Precious Metals call volume above normal and directionally bullish 01/28/21 Wheaton Precious Metals call volume above normal and directionally bullish 01/28/21 Largest borrow rate increases among liquid names 12/09/20 Largest borrow rate increases among liquid names

Earnings	Fulcrum Therapeutics reports Q4 EPS (64c), consensus (72c) » 07:15 03/04/21 03/04 07:15 03/04/21 07:15 FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) Reports Q4 revenue $4.2M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease 12/06/20 Fulcrum Therapeutics presents updated data on SCD program 11/10/20 Fulcrum Therapeutics: Curtis Oltmans to join as general counsel FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 03/01/21 Stifel Fulcrum Therapeutics initiated with a Buy at Stifel 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG FULC Fulcrum Therapeutics $14.59 / +0.59 (+4.21%) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 20 Jan 03/16/21 Healthcare Corporate Access Virtual Day 03/16/21 Healthcare Corporate Access Virtual Day 08:00 Today Fulcrum Therapeutics - FULC
Hot Stocks	Gol Linhas reports preliminary February traffic down 50.3% » 07:15 03/04/21 03/04 07:15 03/04/21 07:15 GOL Gol Linhas $7.32 / -0.03 (-0.41%) Reports preliminary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options GOL Gol Linhas $7.32 / -0.03 (-0.41%) 02/04/21 Gol Linhas reports preliminary January traffic down 37.2% 01/08/21 Gol Linhas provides December investor update 01/06/21 Gol Linhas announces preliminary traffic figures for December 12/27/20 Fly Intel: Top five weekend stock stories GOL Gol Linhas $7.32 / -0.03 (-0.41%) 01/28/21 Deutsche Bank Gol Linhas downgraded to Hold on slowing recovery at Deutsche Bank 01/28/21 Deutsche Bank Gol Linhas downgraded to Hold from Buy at Deutsche Bank 01/12/21 Deutsche Bank Gol Linhas price target raised to $15 from $10 at Deutsche Bank 12/21/20 Santander Gol Linhas downgraded to Hold from Buy at Santander GOL Gol Linhas $7.32 / -0.03 (-0.41%) 01/08/21 Gol Linhas sees Q4 EPS (65c), consensus (36c) 10/09/20 Gol Linhas sees Q3 EPS ($1.15), consensus (61c) GOL Gol Linhas $7.32 / -0.03 (-0.41%) 12/26/20 Delta, Southwest among airline stocks that could cruise higher, Barron's says 12/09/20 Boeing 737 MAX quietly restarts commercial flights in Brazil, Reuters says 12/02/20 Boeing nearing 737 MAX comeback with potential United delivery, Bloomberg says GOL Gol Linhas $7.32 / -0.03 (-0.41%) 09/29/20 Largest borrow rate increases among liquid names
Earnings	Schrodinger sees FY21 revenue $124M-$142M, consensus $177.25M » 07:15 03/04/21 03/04 07:15 03/04/21 07:15 SDGR Schrodinger $99.03 / -7.82 (-7.32%) Sees FY21 software… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options SDGR Schrodinger $99.03 / -7.82 (-7.32%) 02/25/21 Schrodinger expands collaboration with Google Cloud 02/24/21 Schrodinger holder David Shaw sells 457.7K shares of common stock 01/19/21 David E Shaw reports 17.2% passive stake in Schrodinger 12/07/20 Schrodinger presents data from MALT1 inhibitor program at ASH SDGR Schrodinger $99.03 / -7.82 (-7.32%) 01/25/21 BMO Capital Schrodinger price target raised to $117 from $97 at BMO Capital 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement 11/23/20 BofA Schrodinger upgraded to Buy from Neutral at BofA 10/12/20 Jefferies Schrodinger upgraded to Buy from Hold at Jefferies SDGR Schrodinger $99.03 / -7.82 (-7.32%) 07:12 Today Schrodinger reports Q4 revenue $33M, consensus $37.87M 11/12/20 Schrodinger reports Q3 EPS 5c, consensus (7c) 13 Aug SDGR Schrodinger $99.03 / -7.82 (-7.32%) 10/26/20 Fly Insider: Selecta, Netflix among week's notable insider trades 08:30 Today Schrodinger - SDGR SDGR Schrodinger $99.03 / -7.82 (-7.32%) 10/30/20 Largest borrow rate increases among liquid names
Initiation	Royal Gold initiated with an Overweight at JPMorgan » 07:14 03/04/21 03/04 07:14 03/04/21 07:14 RGLD Royal Gold $103.58 / -2.95 (-2.77%) JPMorgan analyst Tyler… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RGLD Royal Gold $103.58 / -2.95 (-2.77%) 02/03/21 Royal Gold sees Q3 stream segment sales 48K-53K GEOs 01/12/21 Royal Gold provides Q2 update 11/17/20 Royal Gold raises annual dividend to $1.20 from $1.12 per share 10/13/20 Royal Gold subsidiary sold 56,000 gold equivalent ounces in Q1 RGLD Royal Gold $103.58 / -2.95 (-2.77%) 07:12 Today JPMorgan Franco-Nevada initiated with a Neutral at JPMorgan 01/11/21 RBC Capital Royal Gold upgraded to Outperform from Sector Perform at RBC Capital 01/11/21 RBC Capital Royal Gold upgraded to Outperform from Sector Perform at RBC Capital 11/23/20 Canaccord Royal Gold upgraded to Buy from Hold at Canaccord RGLD Royal Gold $103.58 / -2.95 (-2.77%) 02/03/21 Royal Gold reports Q2 adjusted EPS 92c, consensus 87c 11/04/20 Royal Gold reports Q1 EPS $1.63, consensus 86c
Upgrade	Kite Realty Group upgraded to Overweight at KeyBanc » 07:14 03/04/21 03/04 07:14 03/04/21 07:14 KRG Kite Realty Group $19.46 / +0.31 (+1.62%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events KRG Kite Realty Group $19.46 / +0.31 (+1.62%) 02/23/21 Kite Realty Group board authorizes new $150M share buyback 09/14/20 Kite Realty Group collects over 89% of Q3 base rent, recoveries KRG Kite Realty Group $19.46 / +0.31 (+1.62%) 05:20 Today KeyBanc Kite Realty Group upgraded to Overweight from Sector Weight at KeyBanc 12/10/20 Wells Fargo Kite Realty Group upgraded to Overweight at Wells Fargo 12/10/20 Wells Fargo Kite Realty Group upgraded to Overweight from Equal Weight at Wells Fargo 08/19/20 Fly Intel: Top five analyst downgrades KRG Kite Realty Group $19.46 / +0.31 (+1.62%) 02/11/21 Kite Realty Group sees FY21 adjusted FFO $1.24-$1.34, consensus $1.32 02/11/21 Kite Realty Group reports Q4 adjusted FFO 33c, consensus 31c 03/16/21 Kite Realty Group 03/16/21 Kite Realty Group 05/12/21 Kite Realty Group Trust

Events

Earnings calls, analyst events, roadshows and more

Today at 07:30

Challenger Job-Cut Report Level: February 2021 Government Event
HCM
Today at 08:00

Hutchison China MediTech - HCM Conference Calls
BALY
Today at 08:00

Bally's - BALY Conference Calls
ATC
Today at 08:00

Atotech - ATC Conference Calls
WVE
Today at 08:00

Wave Life Sciences - WVE Conference Calls
FULC
Today at 08:00

Fulcrum Therapeutics - FULC Conference Calls
Today at 08:00

Consumer Data Analytics Industry Meetings
Today at 08:30

Initial Jobless Claims Change: Week 2/27/2021 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 2/27/2021 Government Event
Today at 08:30

Productivity & Costs: Non-farm Poductivity Annual Rate: Q4(r):2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50-47.00 3.9M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James $34.00-35.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR $11.50-11.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $75.94 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Notable companies reporting before tomorrow's open

TODAY'S FREE FLY STORIES

Get Full Fly Access